[HL-A antigenicity in bladder tumors].
30 patients with papillary transitional bladder tumours were treated by TUR. The stage O and A tumour specimens obtained were examined for presence or loss of antigenicity by the specific red cell adherence test (SRCA). The patients were followed up between 4 and 17 years. A correlation between loss of antigenicity and secondary occurrence of tumours with more aggressive biological behaviour was apparent. Possible therapeutic consequences are discussed.
D002295:Carcinoma, Transitional Cell / Q000276:immunology*; D006680:HLA Antigens / Q000032:analysis*; D006801:Humans; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D001749:Urinary Bladder Neoplasms / Q000276:immunology*
D006680:HLA Antigens
ABH-Antigenität beim Blasentumor.